Delivery Order SPE2DB22D2006-SPE2DB24FW3UL

Award Date 9/26/24
Potential Completion Date 9/27/24
Potential Value $42K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp's Corporate Office division. The $1,163.28 firm fixed-price delivery order is for the supply of 4,565,863,722 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100s. The contract has an ultimate completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $73,404 for the supply of Atovaquone-Proguanil 250-100 100s medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $13,594.70 firm-fixed-price delivery order is for the supply of 4,565,860,237 units of the pharmaceutical product Atovaquone-Proguanil 250-100 in 100-count bottles. The award has a completion date of September 19, 2024 and is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distributor, holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $17,737.50, is a firm fixed price delivery order for the supply of 4,564,071,288 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100s. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a firm fixed price delivery order valued at $70,386.43. The contract was awarded by the Defense Logistics Agency (DLA) to supply Atovaquone-Proguanil 250-100 100s, a pharmaceutical product, with a period of performance through March 22, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime...
This federal contract award, valued at $1,032.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product Atovaquone-Proguanil 250-100 UD 24S. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of...
This federal contract award is for the delivery of Atovaquone-Proguanil 250-100 UD 24S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order worth $4,224.13, with a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $11,233.75 for the supply of 4564616272 ! ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major component of the Department of Defense (DoD) responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces. Amerisourcebergen, a large pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $21,722.79, is a firm fixed price delivery order for ATOVAQUONE-PROGUANIL 250-100 100S, a specialty pharmaceutical product. The award has no set-aside designation and is part of a larger indefinite delivery contract (IDC)...
This federal contract award is for the delivery of Atovaquone-Proguanil 250-100 medication to the Defense Logistics Agency (DLA). The $1,002.18 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW3UL
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of Atovaquone-Proguanil 250-100 100S pharmaceutical products. The $41,897.80 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of Amerisourcebergen. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract has no set-aside designation.

Generated 12/26/24, 9:18 AM